Results 201 to 210 of about 32,727 (251)
Some of the next articles are maybe not open access.

Iron-Chelating Therapy

CRC Critical Reviews in Clinical Laboratory Sciences, 1988
Because of the catalytic action of iron in one-electron redox reactions, it has a key role in the formation of harmful oxygen derivatives and production of peroxidative damage to vital cellular structures. The clinical manifestations of iron overload may be prevented and even reversed by the effective administration of the iron-chelating drug ...
Chaim Hershko   +2 more
openaire   +2 more sources

Iron Chelator Design

1994
The design of an orally active, non-toxic, selective iron chelator has been a goal of many medical chemists over the past twenty years. Naturally occurring siderophores provide excellent models for such molecules, indeed, desferrioxamine has been and still remains an extremely useful iron chelator.
R C, Hider   +3 more
openaire   +2 more sources

CHELATE IRON THERAPY

Journal of the American Medical Association, 1958
Administration of effective doses of iron in the treatment of iron deficiency anemia is complicated by the fact that iron compounds are not innocuous. Toxicity experiments on dogs and rabbits are here summarized; they showed that the concentration of iron attained in the animal's serum determined the severity of the acute symptoms.
M, FRANKLIN   +3 more
openaire   +2 more sources

Chelation of iron by sugars

Biochimica et Biophysica Acta, 1963
Abstract Reducing sugars and polyols are shown to form soluble stable complexes with a series of metal ions at alkaline pH. Several properties of an iron-fructose complex have been studied. The specific conditions of pH and concentrations of iron and fructose necessary for complex formation are described. Evidence for the existence of the complex is (
P J, CHARLEY   +3 more
openaire   +2 more sources

Iron chelation

Current Opinion in Hematology, 2014
This review provides an update on advances in the area of iron chelation therapy, including new indications and uses of currently available agents, and preliminary data on potential new agents in development.Two new oral agents, deferasirox and deferiprone, have become available in the last 8 years.
openaire   +2 more sources

Effects of Iron Chelation in Osteosarcoma

Current Cancer Drug Targets, 2021
Background: Osteosarcoma is an aggressive bone tumor. Itrepresents the principal cause of cancer-associated death in children.Considering the recent findings on the role of iron in cancer, iron chelation has been investigated for its antineoplastic properties in many tumors.
Argenziano, Maura   +8 more
openaire   +3 more sources

Iron chelators and iron toxicity

Alcohol, 2003
Iron chelation may offer new approaches to the treatment and prevention of alcoholic liver disease. With chronic excess, either iron or alcohol alone may individually injure the liver and other organs. In combination, each exaggerates the adverse effects of the other.
openaire   +2 more sources

Iron Chelator Chemistry

2002
Iron overload is a serious clinical condition which can be largely prevented by the use of iron-specific chelating agents. Desferrioxamine-B(1)the most widely used iron chelator in haematology over the past thirty years, has a major disadvantage of being orally inactive’.
Liu, Z D, Liu, D Y, Hider, R C
openaire   +2 more sources

Iron chelation therapy

Current Opinion in Hematology, 1995
Iron chelation therapy is essential to prevent death from cardiac toxicity in patients with thalassemia major or other severe refractory anemias who need regular blood transfusions. Iron chelating drugs also have potential for clinical use as antiproliferative agents in neoplastic diseases and to reduce free radical-induced tissue damage in rheumatoid ...
openaire   +2 more sources

Iron Chelation Therapy

Iron overload is a serious complication associated with transfusion-dependent anemias and anemias characterized by ineffective erythropoiesis. Iron accumulation is toxic to many tissues, causing heart failure, cirrhosis, liver cancer, growth retardation, and multiple endocrine abnormalities.Chelation therapy aims to balance the rate of iron ...
Cappellini, Maria Domenica   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy